Therefore, preserving the quality of samples is at the heart of compound management. Pharma IQ consulted with a selection of experts for their insight on the best ways to enhance sample integrity.
providing tips for improvement and assessing the usual stumbling blocks.
Compound management and biological sample management both have significant influence in the drug discovery process. Compounds of a high integrity contribute to reliable results when locating drug candidates. Additionally, the collection, storage and distribution of human biological materials supports the advancement of the R&D industry, aids understanding of the mechanisms of diseases and fuels the trend to provide personalised medicines.
Last year in Pharma IQ’s Compound Management and Biobanking Activity tracker, around 20 compound management industry members and 28 biobanking industry members examined and pinpointed the most recent trends in both markets over the past year and the predicted trends on the horizon.
This year, we revisit the compound and biobanking markets to pinpoint any shifts or new trends in the market.